Testing effectiveness (Phase 2)Study completedNCT02542787
What this trial is testing
Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis
Who this might be right for
Spasticity in People With Multiple Sclerosis
Canbex Therapeutics Ltd 160